Naglazyme (Galsulfase Vials) 1mg/ml x 5ml

Naglazyme (Galsulfase) is an enzyme replacement therapy supplied in vials for infusion. It helps manage symptoms in certain lysosomal storage disorders. Store between 2–8°C to maintain potency. Always follow healthcare provider instructions for use.

Strength

1mg/ml x 5ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

BioMarin International Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Naglazyme is used to treat symptoms of mucopolysaccharidosis type VI (MPS VI), a rare genetic disorder affecting enzyme function. It helps reduce joint stiffness and improve mobility by replacing the missing enzyme. People often ask, 'what is Galsulfase used for' to understand its role in managing this condition. It is prescribed for long-term enzyme replacement therapy.

Side Effects

Galsulfase works by replacing the deficient enzyme in the body, which may help alleviate symptoms like joint pain and reduced mobility. Patients may notice gradual improvements in physical function over time. The effects vary based on individual health conditions and treatment adherence. Regular monitoring by a healthcare provider is recommended.

Precautions & Warnings

Naglazyme should be handled and administered by trained medical professionals in a clinical setting. Keep vials refrigerated between 2–8°C and protect from light. Do not freeze or shake the vials. Patients should report any signs of allergic reactions immediately. Always follow the prescribed storage and handling guidelines.

Avoid Interactions

Limited data exists on interactions with other medications, but caution is advised when combining with immunosuppressants or other enzyme therapies. Alcohol and certain foods may affect enzyme activity; consult a healthcare provider for personalized advice. Avoid mixing with other drugs in the same infusion line. Monitor for any unusual reactions during treatment.

References

Frequently Asked Questions

Galsulfase is used to treat symptoms of mucopolysaccharidosis type VI (MPS VI), a rare genetic disorder.

Naglazyme is administered via intravenous infusion by a healthcare professional in a clinical setting.

Common side effects may include infusion reactions like fever, chills, or rash. Always discuss concerns with a healthcare provider.

No, Naglazyme should be stored between 2–8°C to maintain its effectiveness. Do not freeze or expose to light.

Yes, Naglazyme is a prescription medication and should only be used under medical supervision.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.